In contrast, although a numerically lower AF probability was also observed in non-diabetic patients receiving SGLT2 inhibitors, this association did not reach statistical significance.
← all excerpts
Association Between SGLT2 Inhibitor Use and New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation: A Doubly Robust Inverse Probability Weighted Analysis
1
—
—